• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常受试者以及接受和未接受噻嗪类药物与磷酸纤维素治疗的结石形成者的结晶尿情况。

Crystalluria in normal subjects and in stone formers with and without thiazide and cellulose phosphate treatment.

作者信息

Hallson P C, Rose G A

出版信息

Br J Urol. 1976;48(7):515-24. doi: 10.1111/j.1464-410x.1976.tb06696.x.

DOI:10.1111/j.1464-410x.1976.tb06696.x
PMID:13904
Abstract

Quantitative and qualitative studies have been made of the urinary crystals from a series of normal subjects and from stone formers with idiopathic hypercalciuria with and without treatment with thiazide diuretics and/or cellulose phosphate. The results obtained from mid-morning unprepared subjects seemed more helpful than those obtained following overnight collections or after a dry breakfast. Crystalluria was more common in stone formers than in normal subjects, but was seen in both groups. The most striking difference between these 2 groups was the almost complete absence of aggregation of oxalate crystals in the normal subjects. Cellulose phosphate greatly reduced phosphate crystals but resulted in a large increase in small oxalate crystals but without change in the incidence of aggregation of oxalate crystals. Thiazides also reduced occurrence of phosphate crystals but only gave a very small increase in oxalate crystals and also without change in aggregation of oxalate crystals.

摘要

对一系列正常受试者以及患有特发性高钙尿症的结石形成者(无论是否接受噻嗪类利尿剂和/或磷酸纤维素治疗)的尿结晶进行了定量和定性研究。从上午中段未做准备的受试者获得的结果似乎比过夜收集或干早餐后获得的结果更有帮助。结晶尿在结石形成者中比在正常受试者中更常见,但在两组中均可见到。这两组之间最显著的差异是正常受试者中草酸盐晶体几乎完全没有聚集。磷酸纤维素大大减少了磷酸盐晶体,但导致小的草酸盐晶体大量增加,但草酸盐晶体聚集的发生率没有变化。噻嗪类药物也减少了磷酸盐晶体的出现,但仅使草酸盐晶体略有增加,草酸盐晶体的聚集也没有变化。

相似文献

1
Crystalluria in normal subjects and in stone formers with and without thiazide and cellulose phosphate treatment.正常受试者以及接受和未接受噻嗪类药物与磷酸纤维素治疗的结石形成者的结晶尿情况。
Br J Urol. 1976;48(7):515-24. doi: 10.1111/j.1464-410x.1976.tb06696.x.
2
A new urinary test for stone "activity".一种用于检测结石“活性”的新型尿液检测方法。
Br J Urol. 1978 Dec;50(7):442-8. doi: 10.1111/j.1464-410x.1978.tb06188.x.
3
Urinary oxalate in summer and winter in normal subjects and in stone-forming patients with idiopathic hypercalciuria, both untreated and treated with thiazide and/or cellulose phosphate.正常受试者以及患有特发性高钙尿症的结石形成患者在夏季和冬季的尿草酸情况,这些患者未接受治疗、接受噻嗪类药物和/或磷酸纤维素治疗。
Urol Res. 1976;4(4):169-73. doi: 10.1007/BF00262350.
4
Resorptive and absorptive hypercalciuria. Therapy with sodium cellulose phosphate or thiazides.吸收性和再吸收性高钙尿症。用磷酸纤维素钠或噻嗪类药物治疗。
Eur Urol. 1979;5(1):29-31.
5
The definition of the mechanism of hypercalciuria is necessary for the treatment of recurrent stone formers.对于复发性结石形成者的治疗而言,高钙尿症机制的定义是必要的。
Contrib Nephrol. 1982;33:136-51. doi: 10.1159/000407071.
6
[Dietary and drug treatments of calcium nephrolithiasis (author's transl)].钙结石的饮食与药物治疗(作者译)
Sem Hop. 1979;55(1-2):7-13.
7
The mechanisms of hypercalciuria are unnecessary for treatment of recurrent renal calcium stone formers.高钙尿症的机制对于复发性肾钙结石形成者的治疗来说并非必要。
Contrib Nephrol. 1982;33:152-62. doi: 10.1159/000407072.
8
Reduction of urine oxalate during long-term thiazide therapy in patients with calcium urolithiasis.噻嗪类药物长期治疗对含钙尿路结石患者尿草酸的降低作用。
Invest Urol. 1980 Sep;18(2):170-3.
9
Studies on crystalluria in calcium oxalate stone formers.草酸钙结石患者的结晶尿研究。
Urol Res. 1984;12(2):103-6. doi: 10.1007/BF00257173.
10
Thiazide does not affect urine oxalate excretion.噻嗪类药物不影响尿草酸排泄。
J Urol. 2003 Aug;170(2 Pt 1):393-6. doi: 10.1097/01.ju.0000076371.92938.9b.

引用本文的文献

1
Histological aspects of the "fixed-particle" model of stone formation: animal studies.结石形成的“固定颗粒”模型的组织学方面:动物研究。
Urolithiasis. 2017 Feb;45(1):75-87. doi: 10.1007/s00240-016-0949-7. Epub 2016 Nov 28.
2
Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement.钙肾结石及其全身表现的代谢诊断与医学预防:共识声明
J Nephrol. 2016 Dec;29(6):715-734. doi: 10.1007/s40620-016-0329-y. Epub 2016 Jul 25.
3
Evaluation of antiurolithic effect and the possible mechanisms of Desmodium styracifolium and Pyrrosiae petiolosa in rats.
广金钱草和石韦对大鼠抗尿路结石作用及其可能机制的评价
Urol Res. 2012 Apr;40(2):151-61. doi: 10.1007/s00240-011-0401-y. Epub 2011 Aug 6.
4
Stone symptoms and urinary deposits.结石症状与尿沉渣
Urol Res. 2010 Feb;38(1):65-9. doi: 10.1007/s00240-009-0227-z. Epub 2009 Nov 4.
5
Photmicrography of urinary deposits in stone clinic.结石门诊尿液沉积物的显微摄影
Urol Res. 2009 Dec;37(6):359-68. doi: 10.1007/s00240-009-0223-3. Epub 2009 Oct 16.
6
Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.草酸钙结晶的尿中抑制剂及其在结石形成中的潜在作用。
World J Urol. 1997;15(3):155-64. doi: 10.1007/BF02201852.
7
Glycosaminoglycans, proteins, and stone formation: adult themes and child's play.糖胺聚糖、蛋白质与结石形成:成人话题与儿童游戏
Pediatr Nephrol. 1996 Oct;10(5):656-66. doi: 10.1007/s004670050185.
8
The scientific basis of calcium oxalate urolithiasis. Predilection and precipitation, promotion and proscription.草酸钙尿路结石的科学基础。易患因素与沉淀、促进因素与抑制因素。
World J Urol. 1993;11(1):59-65. doi: 10.1007/BF00182173.
9
Selected medical aspects of the problem of calcium oxalate stones: a review.草酸钙结石问题的相关医学要点综述
J R Soc Med. 1982 Nov;75(11):897-9. doi: 10.1177/014107688207501115.
10
Experimental induction of crystalluria in rats using mini-osmotic pumps.使用微型渗透泵在大鼠中实验性诱导结晶尿
Urol Res. 1983;11(5):199-205. doi: 10.1007/BF00272279.